Back

Targeting triglycerides: is it worth it? lessons from recent trials

1 September 2024 (11:24 - 11:36)
Organised by: Logo
Congress Presentation Part of: Targeting lipids above and beyond statins: key new players Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Associate Professor Giovanna Liuzzo

IRCCS Foundation Agostino Gemelli University Hospital, Rome (Italy)

4 More presentations in this session

Presentation thumbnail
PCSK9 inhibition: new insights
Professor L. Raber (Bern, CH)
Slides Video
Presentation thumbnail
Strategies to inhibit Lp(a)
Professor F. Kronenberg (Innsbruck, AT)
Slides Video
Presentation thumbnail
Additional cholesterol synthesis inhibition, CETP inhibitors, and cholesterol-efflux enhancer therapies
Professor U. Landmesser (Berlin, DE)
Slides Video
Presentation thumbnail
Targeting lipids above and beyond statins: key new players - discussion
Video

Access the full session

Session thumbnail
Targeting lipids above and beyond statins: key new players
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 11:24 CET
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on cardiovascular residual risk management: role of triglycerides and remnant cholesterol
thumbnail
Congress Presentation
Do triglycerides matter?
thumbnail
Congress Session
Remnant cholesterol and triglyceride-rich lipoproteins in atherosclerosis progression and cardiovascular disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources